Table 1.
Author (years) | Country | Study type | Number of samples | Gender (male) | Average age | Follow-up (months) | Technique of fusion | Outcomes |
---|---|---|---|---|---|---|---|---|
CS/PS | CS/PS | CS/PS | CS/PS | CS/PS | ||||
Hoffman et al. (2019) [15] | USA | Cohort | 23/35 | 16/16 | 48.5/53.4 | 52.5/52.5 | MIDLF/TLIF | 1, 2, 3, 4, 5, 6, 8, 9 |
Marengo et al. (2018) [16] | Italy | Cohort | 20/20 | 12/9 | 45.75/54 | 12/12 | PLIF/PLIF | 1, 2, 3, 4, 6, 8, 9, 10 |
Lee and Ahn (2017) [17] | Korea | RCT | 35/37 | 31/33 | 51.2/51.7 | 24/24 | PLIF/PLIF | 4, 5, 6, 9, 10 |
Takenaka et al. (2017) [18] | Japan | Cohort | 42/77 | 18/31 | 65.8/66.0 | 17/35.4 | PLIF/PLIF | 1, 2, 4, 5, 8, 9, 10 |
Sakaura et al. (2017) [19] | Japan | Cohort | 22/20 | 4/6 | 70.7/68.3 | 39/35 | PLIF/PLIF | 1, 2, 7, 8, 9, 10 |
Peng et al. (2017) [20] | China | Cohort | 51/46 | 23/21 | 62.8/61.9 | 12/12 | PLIF/PLIF | 1, 2, 3, 6, 8, 9, 10 |
Sakaura et al. (2016) [21] | Japan | Cohort | 95/82 | 46/36 | 68.7/67.0 | 39/35 | PLIF/PLIF | 1, 2, 7, 8, 9, 10 |
Orita et al. (2016) [22] | Japan | Cohort | 20/20 | 11/12 | 63.5/63.7 | 12/12 | TLIF/TLIF | 1, 2 |
Hung et al. (2016) [14] | China | Cohort | 16/16 | 6/5 | 60.37/63.12 | 18/18 | PLIF/PLIF | 1, 2, 3, 4, 5, 6, 7 |
Ninomiya et al. (2016) [23] | Japan | Cohort | 11/10 | 7/5 | 62.2/61.4 | 12/12 | PLIF/PLIF | 9 |
Chin et al. (2016) [24] | USA | Cohort | 30/30 | 18/15 | 48/62 | 24/24 | NM/NM | 1, 2, 4, 5, 6 |
Lee et al. (2015) [13] | Korea | RCT | 38/39 | 33/34 | 51.3/51.9 | 12/12 | PLIF/PLIF | 1, 2, 3, 4, 5, 6, 9, 10 |
Outcomes: 1. Blood loss, 2. Operating time, 3. Length of stay, 4. Visual analog score (back pain), 5. Visual analog score(leg pain), 6. Oswestry Disability Index, 7. Japanese Orthopaedic Association, 8. Intraoperative complications, 9. Postoperative complications, 10. Fusion rate. CS: cortical screw PS: pedicle screw RCT: Randomized controlled trial MIDLF: midline lumbar fusion TLIF: transforaminal lumbar interbody fusion PLIF: posterior lumbar interbody fusion NM: not mentioned